Expression of toll-like receptors 2 and 3 on esophageal epithelial cell lines and on eosinophils during esophagitis

Digestive Diseases and Sciences

Volumn 57, Issue 3, 2012, Pages 630-642

  Mulder, Daniel J ^a   Lobo, David ^a   Mak, Nanette ^a   Justinich, Christopher J ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Eosinophil; Eosinophilic esophagitis; Esophagus; TLR2; TLR3; Toll like receptor

Indexed keywords

THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; CYTOKINE; TLR2 PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; EOSINOPHIL; EPITHELIUM CELL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGUS MUCOSA; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ADENOCARCINOMA; BIOPSY; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS; ESOPHAGUS TUMOR; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE;

ADENOCARCINOMA; BIOPSY; CELL LINE, TRANSFORMED; CYTOKINES; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILS; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE EXPRESSION; HUMANS; PRIMARY CELL CULTURE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3;

EID: 84859494433     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1907-4     Document Type: Article

References (41)

1. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342-1363.
2. Mulder DJ, Justinich CJ. Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease. Mucosal Immunol. 2011;4:139-147.
3. Rothenberg ME. Biology and treatment of eosinophilic esophagitis. Gastroenterology. 2009;137:1238-1249.
4. Terhorst D, Kalali BN, Ollert M, Ring J, Mempel M. The role of toll-like receptors in host defenses and their relevance to dermatologic diseases. Am J Clin Dermatol. 2010;11:1-10.
5. Albert EJ, Duplisea J, Dawicki W, Haidl ID, Marshall JS. Tissue eosinophilia in a mouse model of colitis is highly dependent on TLR2 and independent of mast cells. Am J Pathol. 2011;178: 150-160.
6. Yang D, Chen Q, Su SB, et al. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med. 2008;205:79-90. (Pubitemid 351185717)
7. Uehara A, Fujimoto Y, Fukase K, Takada H. Various human epithelial cells express functional toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol. 2007;44:3100-3111. (Pubitemid 46610510)
8. Zhu X, Wang M, Mavi P, et al. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology. 2010;139:182-193.
9. Buckland KF, O'Connor E, Murray LA, Hogaboam CM. Toll like receptor-2 modulates both innate and adaptive immune responses during chronic fungal asthma in mice. Inflamm Res. 2008;57: 379-387.
10. Schroder M, Bowie AG. TLR3 in antiviral immunity: key player or bystander? Trends Immunol. 2005;26:462-468. (Pubitemid 41139255)
11. Lim DM, Narasimhan S, Michaylira CZ, Wang ML. TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2009;297:G1172-G1180.
12. Tsuji K, Yamamoto S, Ou W, et al. dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells. Eur Respir J. 2005;26:795-803. (Pubitemid 41632035)
13. Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ. Bacterial biota in the human distal esophagus. Proc Natl Acad Sci USA. 2004;101:4250-4255. (Pubitemid 38405915)
14. Francois F, Roper J, Goodman AJ, et al. The association of gastric leptin with oesophageal inflammation and metaplasia. Gut. 2008;57:16-24.
15. Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology. 2009;137:588-597.
16. Moqbel R, Lacy P. Molecular mechanisms in eosinophil activation. Chem Immunol. 2000;78:189-198.
17. Rothenberg ME, Spergel JM, Sherrill JD, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet. 2010;42:289-291.
18. Stoner GD, Kaighn ME, Reddel RR, et al. Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res. 1991;51:365-371.
19. Andl CD, Mizushima T, Nakagawa H, et al. Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem. 2003;278:1824-1830. (Pubitemid 36801419)
20. Katayama M, Akaishi T, Nishihira T, Kasai M, Kan M, Yamane I. Primary culture of human esophageal epithelial cells. Tohoku J Exp Med. 1984;143:129-140. (Pubitemid 14034653)
21. Zboralske FF, Karasek MA. Growth characteristics of human esophageal epithelial cells in primary explant and serial culture. In Vitro. 1984;20:109-118. (Pubitemid 15183062)
22. Blanchard C, Mingler MK, Vicario M, et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol. 2007;120: 1292-1300. (Pubitemid 350225686)
23. Vakil N, van Zanten SV, Kahrilas P, et al. The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101: 1900-1920.
24. Sherman PM, Hassall E, Fagundes-Neto U, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol. 2009;104:1278-1295.
25. Flo TH, Halaas O, Torp S, et al. Differential expression of tolllike receptor 2 in human cells. J Leukoc Biol. 2001;69:474-481. (Pubitemid 32221453)
26. Muzio M, Bosisio D, Polentarutti N, et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol. 2000;164:5998-6004. (Pubitemid 30389848)
27. Sanghavi SK, Reinhart TA. Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: implications for inflammation and immunodeficiency. J Immunol. 2005;175:5314-5323. (Pubitemid 41456417)
28. Lane EB, Rugg EL, Navsaria H, et al. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature. 1992;356:244-246.
29. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000;68:7010-7017. (Pubitemid 32463415)
30. van Aubel RA, Keestra AM, Krooshoop DJ, van Eden W, van Putten JP. Ligand-induced differential cross-regulation of tolllike receptors 2, 4 and 5 in intestinal epithelial cells. Mol Immunol. 2007;44:3702-3714. (Pubitemid 46817666)
31. Mayer AK, Muehmer M, Mages J, et al. Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J Immunol. 2007;178:3134-3142. (Pubitemid 46333195)
32. Wang Y, Devkota S, Musch MW, et al. Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon. PLoS One. 2010;5:e13607.
33. Sherrill JD, Gao PS, Stucke EM, et al. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol. 2010;126:160-165.
34. Kato A, Favoreto S Jr., Avila PC, Schleimer RP. TLR3-and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol. 2007;179: 1080-1087.
35. Lee KH, Cho KA, Kim JY, et al. Filaggrin knockdown and tolllike receptor 3 (TLR3) stimulation enhanced the production of thymic stromal lymphopoietin (TSLP) from epidermal layers. Exp Dermatol. 2011;20:149-151.
36. Vu AT, Baba T, Chen X, et al. Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the toll-like receptor 2-toll-like receptor 6 pathway. J Allergy Clin Immunol. 2010;126:985-993.
37. Davicino R, Martinez C, Mattar MA, et al. Larrea divaricata Cav (jarilla): production of superoxide anion, hydrogen peroxide and expression of zymosan receptors. Immunopharmacol Immunotoxicol. 2008;30:489-501.
38. Mullaly SC, Kubes P. Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis. Eur J Immunol. 2007;37:224-234. (Pubitemid 46128802)
39. Martinelli C, Reichhart JM. Evolution and integration of innate immune systems from fruit flies to man: lessons and questions. J Endotoxin Res. 2005;11:243-248. (Pubitemid 41358860)
40. Beutler B. Innate immune sensing of microbial infection: the mechanism and the therapeutic challenge. Wien Med Wochenschr. 2002;152:547-551. (Pubitemid 35440777)
41. Khailova L, Mount Patrick SK, Arganbright KM, Halpern MD, Kinouchi T, Dvorak B. Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2010;299:G1118-G1127.